Related Experiment Video
Updated: Sep 14, 2025

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
Generative artificial intelligence in diabetes healthcare
Josep Vehi1,2, Omer Mujahid1, Aleix Beneyto1
1Modeling and Intelligent Control Engineering Laboratory, Institut d'Informàtica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.
Abstract:
The rapid advancement of generative artificial intelligence (AI) has been fueled by breakthroughs in large language models and applications across diverse domains, from creative content to scientific discovery. Its strength lies in modeling, simulating, and generating high-fidelity data. In diabetes care, generative AI enables solutions to challenges such as data scarcity, patient variability, and personalization. This article explores key deep generative models, including variational autoencoders, generative adversarial networks, transformers, and diffusion models applied to tabular, time series, image, and text data. These models enable synthetic patient data generation, dataset augmentation, glucose-insulin dynamics simulation, and the development of virtual coaches and digital twins. Despite these advances, challenges persist, including model instability, high data requirements, and output interpretability. This article reviews the current literature and outlines opportunities, limitations, and ethical considerations for the use of generative AI in diabetes healthcare.
More Related Videos
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Non-equilibrium in the Cell
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

